Vanadium complexes with mixed O,S anionic ligands derived from maltol: synthesis, characterization, and biological...

Area of Science:

• Inorganic Chemistry
• Medicinal Chemistry
• Coordination Chemistry

Background:

• Maltol derivatives are explored for their potential biological activities.
• Vanadium complexes are investigated for their insulin-mimetic properties.
• O,S-binding ligands offer unique coordination environments for metal ions.

Purpose of the Study:

• To synthesize and characterize novel vanadium complexes using maltol-derived O,S-bidentate ligands.
• To evaluate the insulin-enhancing effectiveness of these new vanadium complexes in a rat model of diabetes.
• To investigate the metabolic profile of a promising vanadium complex.

Main Methods:

• Synthesis of four O,S-bidentate ligand precursors: thiomaltol (Htma), ethylthiomaltol (Hetma), HmpPt, and Hdppt.
• Chelation of ligands to vanadium to form bis(ligand)oxovanadium(IV) and tris(ligand)vanadium(III) complexes.
• Characterization using elemental analysis, mass spectrometry, IR, EPR, and X-ray crystallography.
• In vivo testing for insulin-enhancing activity in streptozotocin-induced diabetic rats.
• Metabolic profiling of VO(tma)(2) for vanadium and ligand clearance.

Main Results:

• Four new vanadium complexes were successfully synthesized and characterized.
• The X-ray structure of oxobis(thiomaltolato)vanadium(IV), VO(tma)(2), revealed cis and trans isomers.
• None of the new vanadium complexes demonstrated acute blood glucose lowering effects in diabetic rats.
• Rapid dissociation and excretion of the complexes may explain the lack of acute efficacy.

Conclusions:

• Novel O,S-bidentate vanadium complexes were prepared and structurally elucidated.
• The synthesized vanadium complexes did not exhibit acute insulin-enhancing activity in vivo.
• Further studies are needed to explore potential long-term effects or alternative therapeutic applications.